Corrigendum to 'COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)': [ESMO Open Volume 6, Issue 3, June 2021, 100165]

ESMO Open. 2021 Aug;6(4):100243. doi: 10.1016/j.esmoop.2021.100243. Epub 2021 Aug 2.

¹ Fondazione IRCCS Casa Sollievo della Sofferenza, Cancer Biomarkers Unit, San Giovanni Rotondo.
² Department of Oncology, University of Torino, Candiolo, Turin; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin.
³ Molecular Oncology Unit Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano.
⁴ Biogem, Institute for Genetic Research 'G. Salvatore', Ariano Irpino.
⁵ Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin.
⁶ Laboratory of Immunology, Unit of Molecular Pathology, Immunology and Biochemistry, IRCCS MultiMedica, Milan.
⁷ Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome.
⁸ Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan.
⁹ Department of Experimental and Clinical Biomedical Sciences, School of Medicine, University of Florence, Florence.
¹⁰ Fondazione IRCCS Istituto Nazionale Tumori, Milan.
¹¹ Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
¹² Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: [email protected].

No abstract available

Publication types